BPC-157 Sebopeho: Hobaneng “99% Hloekileng” Ha hoa lekana

BPC-157 Sebopeho: Hobaneng “99% Hloekileng” Ha hoa lekana

Tsoelo-pele ke ea 'Nete, empa E itšetlehile Mohloling o le Mong

molumo oa ho batla kapa oa phepelo ea sechaba o koahetsoeng ka setempe sa qotso ea mohloli o le mong, e fana ka maikutlo a lihlooho tse ngata tse phetang tšimoloho e le 'ngoe

Tlhokahalo ea BPC-157 e ntse e phahama e le kannete, 'me bopaki ba ho phahama hoo bo tšesaane ho feta kamoo lihlooho tsa litaba li bontšang kateng. A 2025 tlhahlobo e hlophisitsoeng ka HSS Journal e fumane hore bophahamo ba patlo ea Google BPC-157 bo fihlile holimo ka Phuptjane 2024, ka tse fetang 50 maikutlo a limilione a BPC-157 a tšoailoeng ho YouTube le TikTok le ho feta 100,000 litho tsa sechaba se amanang le peptide Reddit. Seo ke sesupo sa sebele, hape ke mohloli o le mong o holimo: Lingoliloeng tse ngata tsa "BPC-157 e ntse e phatloha" tse phatlalalitsoeng ho tloha morao ho tlhahlobo ena e le 'ngoe.

Palo ea lehlakore la kliniki e fokola le ho feta. Reuters e tlalehile ka sekhetho sa pele se bonts'itseng 1,039 bakuli ka mose ho feta 15 lirekoto tse limilione, ka keketseho ea makhetlo a 33 ho basebelisi ba netefalitsoeng lipakeng tsa 2020 le 2026. Khatiso eo ha e so hlahlojoe ke lithaka, e leng taba ha datha e le 'ngoe e sa hlahlojoang e etsa mosebetsi o mongata moqoqong.

Key Takeaway: Litlaleho tsa Momentum ka BPC-157 li boima haholo. Pele o pheta palo ea kholo, bolela thuto ka mor'a eona le hore na e hlakotse tlhahlobo ea lithaka.

BPC-157 Sebopeho: Hobaneng "99% E Hloekileng" Ha hoa lekana

Ha ho le e 'ngoe ea sena e etsang hore lebelo leo e be leshano. E etsa hore potso ea tlhaloso e be ntho ea pele eo 'mali ea hlokolosi a e botsang, mme e theha bothata bo boima ho feta: palo e ntseng e eketseha ea basebelisi e fanoa ke lihlahisoa tseo litseko tsa tsona tsa boleng li itšetlehileng ka palo e fokolang ho feta kamoo e bonahalang kateng. Lekhalo leo ke moo sebopeho sa BPC-157 se qalang teng.

Pono e Tloaelehileng: Bohloeki Ke Pale Eohle

Boemo bo tloaelehileng bo bonolo: chromatography ea mokelikeli e sebetsang hantle haholo (HPLC) setšoantšo sa bohloeki setifikeiting sa tlhahlobo (CoA) ke bopaki bo lekaneng ba hore peptide ke sehlopha sa lipatlisiso. Ka monahano oo, 99% ke khoele ea ho qetela, le eng kapa eng e ka holimo 98% e fapanyetsanoang.

Ho bonolo ho bona hore na ke hobane'ng ha shorthand ena e ile ea tšoara. Bohloeki ke palo e le 'ngoe, e ka bapisoang le bafani ba thepa, e ka hatisoang leqepheng la sehlahisoa, mme e balehe ho moreki ya nang le metsotsoana e mashome a mararo ho etsa qeto. E hatella mohopolo o nepahetseng oa tlhahlobo ho yuniti ea papatso.

Lipalo-palo tse hatisitsoeng ke barekisi li kopana ka thata ka holimo ho sekala seo. Litlhoekiso tse thathamisitsoeng phatlalatsa tsa BPC-157 li kenyelletsa 98.329%, 99.41%, 99.54%, 99.55%, 99.74%, 99.8%, le 99.86%, le aggregator e le 'ngoe e tlalehile mokhoa oa 99.52% ka nqane 18 liteko ka mefuta e mengata ea 99.02% ho 99.90%. Linomoro tsena li itlhahisa ebile ha li laolehe, kahoo li nke e le lipapiso tsa mokhoa oa ho rekisa ho e-na le lipalo-palo tsa 'maraka.

Bakeng sa Keletso: Bala palo ea bohloeki e le tleleime e mabapi le lintho tse ngata, eseng joalo ka thepa ea molek'hule. Nomoro ntle le mokhoa, kholomo, 'me bolelele ba maqhubu a ho lemoha ke kakaretso ea qeto ea motho e mong, e seng bopaki ka mora yona.

Phapang ke CoA e feletseng. E matla e amahanya karolo e le 'ngoe ho liphetho tsa laboratori tse rehiloeng le mekhoa ea litlaleho hammoho le boleng: boitsebiso ka spectrometry ea boima khahlanong le boima ba maikutlo, HPLC bohloeki ka kholomo, mobile-phase gradient le ho lemoha wavelength (ka tloaelo 214 nm), boemo bo sa hloekang, mofuta oa counterion kapa letsoai, mongobo kapa bokahare ba peptide, sephetho sa endotoxin ea linomoro tse nang le likarolo le tlhahlobo, sterility moo ho boleloang, hammoho le nomoro ea lotho, letsatsi la teko, laboratori ea tlhahlobo, sekhetho sa mohlala le tumello (mokhoa oa ho bala peptide CoA, 2026-05-24). Eo ke tekanyetso ea litokomane eo setifikeiti sa nomoro e le 'ngoe se lokelang ho ahloloa ka sona, mme ke moo pono e tlwaelehileng e qalang ho arohana.

Ke Hobane'ng ha Bohloeki bo le Mong bo hloleha joalo ka BPC-157 Characterization

sampole e fetotsoeng ea CoA e nang le mohala oa bohloeki o totobalitsoeng le libaka tse sieo - gradient, bolelele ba maqhubu, likarolo tsa endotoxin, lotto traceability - bitsoa i

Peresente ea bohloeki e araba potso e le 'ngoe hantle: bokae ba seo sebui se se boneng boteleleng bo le bong e ne e le tlhoro e kgolo. Ha e u bolelle hore na molek'hule ke BPC-157, kamoo e entsoeng kateng, e jere counterion efe, kapa ke eng hape e ka hara vial. Sebopeho sa BPC-157 ke bothata ba li-axis tse ngata, 'me bohloeki ke sebaka se bapalang habonolo.

Boitsebiso ke lekhalo la pele. Teko e ikemetseng ea lab ea WIRED ea linkho tsa mabenkele tsa peptide e fumane hore lihlahisoa tsa sampole "li ne li se na metsoako e sebetsang mangolong a tsona., BPC-157, ka mohlala, e ne e se na BPC-157 ka hare ho eona,” le sehlopha sa bobeli se hlahlobiloeng ke Analytical Formulations ha lia ka tsa tsejoa ka nepo (KHOPOTSO, Loetse 2026). A 99% palo e holim'a vial e se nang BPC-157 hase letšoao la boleng. Ke tekanyo ea ntho e fosahetseng.

Mokhoa oa ponaletso ke lekhalo la bobeli. Bohloeki bo itšetlehile ka mokhoa: sampole e tšoanang e ka fetoha ka ntlha ea liperesente kapa ho feta ka liphetoho ho kholomo, gradient le litlhophiso tsa ho lemoha, kahoo palo ntle le maemo a HPLC a boletsoeng e ke ke ea bapisoa ho barekisi kapa lihlopha (ChemVerify, 2026-06-14). Nomoro e sirelelitsoeng e bolela kholomo, the mobile-phase gradient le bolelele ba maqhubu a ho lemoha, ka tloaelo 214 nm. Lisetifikeiti tse ngata li siea tse tharo kaofela.

Lekhalo la boraro ke tšilafalo. Tlhahlobo e kholo ka ho fetisisa e hatisitsoeng ea 'maraka oa bohlooho ho fihlela joale e fumane hore 41.6% ea lisampole e ile ea hloleha ho benchmark e bonolo e kopantsoeng ea lithethefatsi le 71.1% e hlolehile ho latela tekanyetso e thata ea lithethefatsi tse entsoeng, ka nako e batlang e lekana 2.4% e ne e se na letho la peptide e ngotsoeng le 15% ea karolo e lekiloeng ea endotoxin e bonts'itse endotoxin ea baktheria e ka lekanngoang (Finnrick, 2026). Teko ea peptide endotoxin ke eona feela tsela ea ho bona mokhoa oo oa ho qetela oa ho hloleha; chromatogram e hloekileng e ke ke ea hlola e e-ba teng.

⚠️ Tlhokomeliso: Tlhahlobo ea Finnrick e tlaleha palo ea mehlala ea eona e sa tsitsang likarolong tsohle, 6,441 sebakeng se le seng le 6,285 ho enngwe. Phapang ha e so rarolloe, kahoo tšoara liphesente joalo ka tataiso ho e-na le ho nepahala.

Bohloeki ke mokoloko o le mong. Boitsebiso, mokhoa pepeneneng le tšilafalo ke tse ling, mme palo e le nngwe ga e kgone go di rwala.

Seo Boitsebiso bo hlileng bo se Bontšang ka BPC-157 Characterization

sebopeho sa sebopeho sa mahlakore a mahlano se nang le boitsebiso, bohloeki, boemo bo sa hloekang, endotoxin le litokomane tse tsoang ho sampole e bohareng, axis lab ka 'ngoe

Reframed khahlano le seo balaoli ba hlileng ba se kopang, Sebopeho sa BPC-157 se khaotsa ho ba tlhōlisano ea bohloeki 'me e fetoha bothata ba tiiso. Tataiso ea EMA ho li-peptide tsa maiketsetso, e qala ka June 2026, e lebeletse "bonyane mekhoa e 'meli ea orthogonal ... bakeng sa boitsebiso" le ho lekola bohloeki ho pholletsa le boholo-, tefiso- le likarohano tse thehiloeng ho hydrophobicity, mme e bolela ka ho hlaka hore ICH Q3A ha e sebetse ho li-peptide tsa maiketsetso. Netefatso ea Orthogonal, eseng nomoro ea sehlooho, ke tlhokahalo.

Identity ka boeona ke stack, e seng teko e le nngwe: bongata bo sa fetoheng hammoho le ts'ebetso ea tatelano ea 'mapa oa peptide, tlhahlobo ea amino acid bakeng sa sebopeho, le tharollo ea chromatographic ea mefuta e fapaneng ea tatelano e amanang haufi-ufi, ka sebopeho sa maemo a holimo se hlahlobiloeng ke circular dichroism le DSC moo ho hlokahalang, ho kenyelletsa naha ea oligomeric. Endotoxin e latela mohopolo o tšoanang. The USP 〈85〉 moralo oa moeli oa endotoxin e hlokomela mekhoa e meraro e netefalitsoeng e thehiloeng ho LAL, e nang le kutlo e tloaelehileng ea gel-clot ea 0.03–0.25 EU/mL le mefuta ea turbidimetric kapa chromogenic ea 0.001–100 EU/mL, mme e beha meeli ho tloha ho K/M, moo K 5.0 EU/kg bakeng sa intravenous le 0.2 EU/kg bakeng sa lihlahisoa tsa intrathecal.

Axis

E araba potso eo

Bopaki bo e arabang

Ho hloleha hoa tšoara

Boitsebiso

Na ena ke molek'hule e nepahetseng?

Boima bo sa feleng, 'mapa oa peptide, tlhahlobo ea amino acid

Tatelano mefuta e fapaneng le tse ling

Bohloeki ka mokhoa o pepeneneng

Peptide e shebiloeng ke bokae?

Ho arohana ha Orthogonal ho pholletsa le boholo, tefiso, hydrophobicity

Nomoro e le 'ngoe e patang litšila tse kopaneng

Ho se hloeke le boemo ba counterion

Ke eng hape e teng?

Teko e amanang le lithethefatsi le counterion

Li-solvents tse setseng, TFA, tatellano e fokoditsweng

Peptide Synthesis Endotoxin

Na e bolokehile bakeng sa tsela e reriloeng?

Mokhoa o netefalitsoeng oa LAL Li-Peptide tsa Synthetic khahlano le meeli ea K/M

Ho pepesehela endotoxin ka tsela e khethehileng

Litokomane le traceability

Na e 'ngoe ea tsena e ka hlahlojoa?

Setifikeiti sa tlhahlobo, lintlha tsa mokhoa, lirekoto tsa batch

Litlhahiso tse ke keng tsa etsoa hape

Mohlala ona oa li-axis tse hlano ke motsoako oa litekanyetso tse hatisitsoeng, eseng tleleime e ncha. E hlophisa feela seo litokomane tsa EMA le USP li seng li se hloka lipotsong tseo moreki a lokelang ho li botsa pele a amohela palo ea bohloeki..

Likheo Tsa Mahlale ke Pale ea 'Nete

Bothata ba BPC-157 ha se taba ea tlhaho. Ke ho ba sieo ha motheo oa saense ea ho qapa, pharmacokinetics e netefalitsoeng, le liteko tse laoloang tsa katleho ea batho, e leng kamoo ho 2026 Litlhare tsa meriana hlahloba liforeimi lebaleng (Mateescu et al., Litlhare tsa meriana 18(5):625, kgutlisitsoe 2026-05-20). Tlhahlobo e tšoanang e bala palo eohle ea bopaki ba batho e hatisitsoeng e le lithuto tse tharo tsa lifofane tse sa laoleheng tse nang le ngoliso e kopanetsoeng tlas'a 30 bafo: letoto la mahlaba a mangole a 16 bakuli, ea mang 12 e amohetse intra-articular BPC-157 feela; mofofisi oa interstitial cystitis oa 12 basadi; le mofofisi oa tšireletso ka methapo ea 2 batho ba baholo ba phelang hantle.

Se sieo se totobetse. Ha ho na sebopeho se netefalitsoeng sa boemo ba meriana, ha ho na sebopeho se hlophisitsoeng sa permeability kapa sehlopha sa BCS, ha ho lithuto tsa excipient-compatibility, tharollo e sa rarolloang le botsitso ba polokelo, pharmacokinetics ea batho e sa hlalosoang hantle, mme ha ho na mokhoa o netefalitsoeng oa bioanalytical oa motho. Bioavailability ea molomo ha e tsejoe, Li-pharmacokinetics tsa subcutaneous ha li amoheloe, tlamahano ea protheine ea plasma ha e so phatlalatsoe, 'me boholo ba kabo ha bo lekanngoe.

Mokhahlelo o le mong o ngolisitsoeng 2 randomized, sefofu habeli, teko ea hamstring-strain e laoloang ke placebo (NCT07437547) lipheo 120 barupeluoa 'me hajoale e ntse e thaotha. Ha e so tlalehe liphetho, kahoo ha e phethoe Mokhahlelo 2 bopaki.

Esita le setšoantšo sa bibliometric se itšetlehile ka hore na u bala joang. Patlo e le 'ngoe ea khutla 227 Lingoliloeng tsa BPC-157 tse nang le 53 direkoto tse amanang le batho; e mong oa khutla 232 lipampiri tse nang le 54 e tšoailoe ke motho (PeptideDeck, Lipalopalo tsa BPC-157, 2026). Phapang ke boholo ba lipotso, ke ka lebaka leo palo efe kapa efe ea likhatiso e hlokang khoele ea eona ea ho batla e boletsoe.

Likheo tsena ke khang ea taeo ea sebopeho sa BPC-157: ha lingoliloeng tsa bongaka li sa khone ho u joetsa hore na tokiso e etsa eng ho batho, litokomane tsa se hlileng se leng ka har'a vial li na le boima bo bongata, eseng ka tlase. Tlhahiso ea Peptide

Setšoantšo sa Taolo ha se rarolloe, Ha ea Lula

Litšebeletso Ka Phupu 2026 boutu ea boeletsi e fetotse moqoqo, eseng molao. E butsoe 2026-07-23, Komiti ea Boeletsi ea Pharmacy Compounding e ile ea khetha 8 molemong, 6 kgahlanong le, ka 1 ho ila, ho khothaletsa setsi sa mahala sa BPC-157 le acetate bakeng sa lenane la bongata ba Karolo ea 503A, leha lisebelisoa tsa bokhutšoane tsa basebetsi ba FDA li hlahisitse sephetho se fapaneng, joalo ka McDermott Will & Emery o balile ka ts'ebetso ea lenane la bongata ba 503A litlaleho. Ho tloha ka September 2026, ha ho ketso ea ho qetela ea FDA e latetseng, 'me khetho feela ha e etse hore BPC-157 e kopane ka molao: li-bulks-list placement plus notice-and-comment rulemaking li ntse li hlokahala.

Phapang eo e bohlokoa ka tsela e fapaneng le ba amehang. Bafuputsi ba lokela ho tšoara mofani e mong le e mong ea fanang ka maikutlo a hore voutu e ngolisitsoe ka molao ea BPC-157 e emela boemo bo fosahetseng.. Lihlopha tsa ho reka le tsa QC li lokela ho boloka litekanyetso tsa litokomane tsa peptide tsa lipatlisiso li hokahane le se hlileng se ka netefatsoang kajeno., eseng ho molao o ntseng o emetse. Bafani ba thepa ba tobana le lekhalo le tšoanang lipakeng tsa khothaletso le boemo bo molaong. Balaoli, khabareng, ha ke so rarolle potso ho hang.

Boemo ba FDA ka boeona bo ntse bo lerootho. BPC-157 ha e lumelloe ke FDA bakeng sa pontšo efe kapa efe, 'me ha ho setlhare se feliloeng se lumelletsoeng se nang le eona. Leqephe la kotsi la ts'ireletso la setsi le beha BPC-157 har'a lithethefatsi tse ngata tseo mabitso a tsona a tlositsoeng., ho bolela hore lithethefatsi tse kopantsoeng tse nang le eona li ka baka likotsi tsa ho itšireletsa mafung bakeng sa litsela tse itseng tsa tsamaiso 'me li ka ba le mathata a amanang le litšila tse amanang le peptide le sebopeho sa API., le hore FDA e khethile che, kapa e lekanyelitsoe feela, tlhahisoleseding e amanang le polokeho bakeng sa litsela tse sisintsweng tsa tsamaiso (FDA, dikahare tsa jwale 2026-04-22).

Mokhoa oa ho Sebelisa Sena: Lethathamo la Litšobotsi

lethathamo la lintlha tse hlano tsa kopo ea litokomane tse fanoeng e le foromo eo moreki a ka e manamisang ka har'a lipatlisiso tsa mofani oa thepa.

Kopa mokhoa oo, eseng palo. Kopo e le 'ngoe ke tsela e potlakileng ea ho arola morekisi ea utloisisang lipatlisiso tsa litekanyetso tsa litokomane tsa peptide ho tloha ho ya phetang papadi ya ho bapatsa, mme e o jella lengolo-tsoibila le le leng.

  1. Kopa CoA e khethehileng haholo. Netefatsa setifikeiti sa tlhahlobo bakeng sa li-peptide tsa lipatlisiso bolela nomoro ea lotho, laboratori ea liteko, le letsatsi la teko. Tokomane e sieang leha e le efe ho tse tharo e ke ke ea tlamelloa ho thepa e ka pel'a hao.

  2. Hlahloba hore na bopaki ba boitsebiso bo na le orthogonal. Tlhōrō e le 'ngoe ea HPLC ke mokhoa o le mong o arabang potso e le' ngoe. Boitsebahatso bo matla ha motsotsoana, mokhoa o ikemetseng oa lumellana.

  3. E hloka liparamente tsa mokhoa oa HPLC. Kholomo, gradient, 'me bolelele ba maqhubu bo haufi le boleng ba bohloeki. Ntle ho tsona, peresente ha e khonehe hape.

  4. E hloka sephetho sa endotoxin ea linomoro tse nang le li-unit le assay. Teko ea peptide endotoxin e lokela ho tlaleha EU/mL bakeng sa tharollo maemong a hlalositsoeng a sebetsang, kapa EU/mg ha e tloaelehile ho boima ba peptide, mme e lokela ho ngola taolo e ntle ea sehlahisoa ka ho hlaphoheloa ha spike (kamohelo e qotsitsoeng hangata ho pota 50 ho 200%) mmoho le dilution e nepahetseng e hlalositsweng, hobane li-peptide li ka thibela kapa tsa ntlafatsa lets'oao la LAL (Tataiso ea tlhahlobo ea Assyro endotoxin, kgutlisitsoe 2026-09-14).

  5. Netefatsa foromo ea counterion kapa letsoai, mongobo kapa bokahare ba peptide, le batch traceability. TFA le Reka letsoai la acetate le itšoara ka tsela e fapaneng, 'me litaba tsa peptide tsa net li fetola tsela eo u balang mahloriso a sebetsang ka eona.

Khetho e le 'ngoe har'a tse' maloa: mofani oa thepa ea sebetsang ka Sehlopha 100 kamore e hloekileng e nang le HPLC ea ka tlung, MOF, 'me sterility QC e ka sebelisoa ho kopanya sephutheloana se ikhethileng sa batch ho milligram ho isa ho kilogram., e tshehetsang kopo ya ditokomane ho ena le ho e nkela sebaka.

Lekanya karabo, eseng tshepiso. Morekisi ea arabang lipotso tsa mokhoa o u bolella ho hong; motho ea khelohelang setšoantšong sa bohloeki o ntse a u bolella haholoanyane. Lebella karabo ea litokomane ka mor'a matsatsi. Sephetho sa lipatlisiso se nka nako e telele haholo.

Malemo: Moo Khang Ena E Fokolang Ka ho Fetisisa

Sephutheloana se matla sa litlhaku se ntse se ke ke sa etsa hore se se amoheloe, peptide e sa ithutoang e bolokehile kapa e sebetsa hantle, 'me litokomane tse betere ha li nke sebaka sa bopaki ba bongaka. Haho letho mona le fetolang seo.

Moralo oa li-axis tse hlano ke motsoako oa litekanyetso tse hatisitsoeng, ha se protocol e le 'ngoe e qotsitsoeng. Tataiso ea EMA ke kakaretso ea bobeli, mme mohloli ka boona o re liphesente tsa eona li lokela ho netefatsoa khahlano le sengoloa sa mantlha. Palo ea sampole ea tlhahlobo ea Finnrick ha e lumellane lipakeng tsa likakaretso. Palo ea kholo ea basebelisi ba nference e tsoa khatisong ea pele, 'me lipalo tsa PubMed li itšetlehile ka lipotso.

Pono ea bohloeki-pele e ka itšireletsa libakeng tse ling. Bakeng sa motho ea ikhethang, peptide e amohetsoeng e nang le monograph e netefalitsoeng, setšoantšo sa bohloeki se na le boima bo bongata ho feta mona, hobane boitsebiso, boemo bo sa hloekang, le meeli ea endotoxin e se e behiloe ke monograph.

Khang ke hore sebopeho sa BPC-157 sea hlokahala, e sa lekaneng.

Empa Na Nomoro e Phahameng ea Bohloeki e ntse e mpolella ho hong?

E etsa joalo, but only in combination with two other pieces of information: the method that produced the figure and the identity evidence confirming what the peak actually was. A 99.8% result from one lab’s HPLC run is not the same claim as a 99.8% result from another, because the number depends on the gradient, the detection wavelength, and the standard curve behind it. Without the method, the figure is a measurement of something, not necessarily of BPC-157.

If you have already purchased vials on the strength of a purity figure, discarding them on assumption is not the only option. Request the underlying method documentation from the supplier and, where the material matters to your work, commission independent identity and endotoxin testing. That converts an unverified claim into a documented one, and it costs far less than restarting a study.

The PCAC vote is worth addressing directly, because it is frequently read as a green light. It was an advisory vote, it was split, and FDA staff recommended against inclusion. No final rulemaking has followed. The gap between a committee recommendation and a lawful status is the whole point.

On endotoxin, the objection is usually that it is overkill for laboratory work. Whether it is depends on route and dose, and the limit that applies is set by those two variables rather than by the setting. The reason the question gets asked at all is that 15% of the audited subset showed measurable endotoxin. That is not a reason to test everything indiscriminately; ke lebaka la ho tseba hore na u araba potso efe pele u etsa qeto ea hore ha ho hlokahale hore u e botse. About

Qetello: Sebopeho se Lokela ho Hlalosa Lipatlisiso-Kereiti ea BPC-157

Purity-first shorthand ke kopano ea papatso, eseng tekanyetso ea tlhahlobo, le sebopeho sa BPC-157 se qala moo shorthand eo e fellang teng: netefatso ya boitsebiso ba orthogonal, bohloeki bo bonaletsang mokhoa, ho se hloeke le ho hanyetsana, tlaleho ea endotoxin ea linomoro, le litokomane tsa boemo bo bongata tseo mohlahlobisisi a ka li hlahlobang.

Phetoho eo khang ena e e batlang e se e ntse e bonahala mabapi le hore na lihlopha tse matla ka ho fetisisa tsa ho reka thepa li sebetsa joang. Ba botsa lipotso tsa mokhoa pele ho lipotso tsa theko. Ba nka setifikeiti sa tlhahlobo bakeng sa li-peptide tsa lipatlisiso e le tokomane e qalang ho fapana le e koalang, 'me ba lebeletse hore barekisi ba phatlalatse li-gradients, litšiea, le ho lemoha wavelengths sebakeng sa peresente e le nngwe. Ha tebello eo e ntse e ata, ho etsa lipatlisiso ka litekanyetso tsa litokomane tsa peptide e khaotsa ho ba boitlamo ba morao-rao 'me e be pokello ea mantsoe a puisano ea ho reka ka boeona..

Nahana ka 'maraka o latelang: a 99% palo e se nang mothako o itseng e baleha joalo ka karabo e sa phethahalang, eseng sebaka sa ho rekisa. Eo ke bar e holimo, 'me ke eona ntho e lokeloang ke ho etsa lipatlisiso.

Mohato o latelang: Lekola litlhoko tsa rona tsa litokomane 'me u kope leqephe la lintlha pele ho potoloho ea hau e latelang ea mangolo.

Tsebiso: MOL Changes e phatlalatsa e le morekisi oa peptide, kahoo tšoara tlhahlobo ena e le pono e le 'ngoe ka har'a 'maraka oo e kopanelang ho oona.

Admin Avatar

Zejun Peng

Ofisiri e ka Sehloohong ea Theknoloji; Setsebi sa Peptide Synthesis Tsebo ea Konokono: Motsoako o rarahaneng oa peptide, liphetoho tse seng tsa tlhaho tsa amino acid, le kaho ea cyclic peptides le stapled peptides.

Biography:Zejun Peng o na le boiphihlelo bo batsi ho chemistry ea tlhaho le peptide synthesis. O na le tsebo ea ho sebelisa motsoako oa peptide e tiileng-mohato (SPSS) le motsoako oa li-peptide tsa metsi (LPPS), 'me o na le tsebo e khethehileng ea ho hlola "tatelano eo ho leng thata haholo ho e kopanya" (joalo ka li-peptide tsa ultra-long-chain, tatelano e phahameng haholo ea hydrophobic, le multiple disulfide bond mene). Tlas'a boetapele ba hae, sehlopha se atlehile ho hlola mathata a tekheniki ka liphetoho tse 'maloa tse khethehileng (joalo ka N-methylation, PEGylation, le ho ngola fluorescent), ho boloka sekgahla sa katleho se qadileng hofeta 98%.

'Nete e hlahlobiloe & Litaelo tsa Bahlophisi
E hlahlojoa ke: Litsebi tsa Litaba
Arolelana sehlooho sena
Lehae Batla Whatsapp Litšebeletso Sehlahisoa